Atlas Trials

A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer

Clinical trial NCT03168880 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03168880
Sponsor
Tata Memorial Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Triple Negative Breast Cancer
Start date
2010-04-01
Primary completion
2025-11-30
Enrollment
720

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.